Actinogen Medical Limited (ATGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
Jan 29, 2026, 4:00 PM EST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of $97.76 million as of February 2, 2026. Its market cap has increased by 100.69% in one year.
Market Cap
97.76M
Enterprise Value
88.55M
Revenue
3.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 11.50M to 97.76M, an increase of 750.20%. That is a compound annual growth rate of 12.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 98.21M | -24.26% |
| Dec 31, 2025 | 129.67M | 167.53% |
| Dec 31, 2024 | 48.47M | 40.08% |
| Dec 29, 2023 | 34.60M | -71.81% |
| Dec 30, 2022 | 122.77M | -40.54% |
| Dec 31, 2021 | 206.48M | 778.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 227.67M |
| HST Global | 139.70M |
| Vaxart | 139.14M |
| BioStem Technologies | 103.69M |
| Nuo Therapeutics | 83.58M |
| VitaSpring Biomedical | 51.78M |
| Arch Biopartners | 51.20M |
| Vicapsys Life Sciences | 48.56M |